Optimizing treatment models for uterine cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical, therapeutic, and prognostic relevance of new experimental results in patients with uterine neoplasms. It aims to optimize therapeutic models and develop a new algorithm for creating personalized treatment plans. The study focuses on patients with confirmed uterine malignancies who are undergoing surgical therapy. Data will be collected to assess the effectiveness of these new approaches in improving patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)
* If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery
* Written consent
* Willingness and ability to participate in all study-specific procedures
* Age ≥ 18 years

Exclusion Criteria:

* Severe and acute general disease in the last 4 weeks
* Acute or chronic psychiatric disorders
* Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)

Where it's running

• University Hospital Tuebingen, Department of Women's Health
  Tübingen, Germany Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oral Progestin Tablets With Radiotherapy vs. Standard Radiotherapy and Chemotherapy in High-Risk NSMP Endometrial Cancer

  This trial tests whether adding oral progestin tablets after radiotherapy is as effective as the standard radiotherapy plus chemotherapy for high-risk NSMP endometrial cancer, hoping to reduce side effects and improve quality of life.

  Recruiting at 12 sites Phase 3 University College, London · Bath and 11 other locations · NCT07831902

• AI into Ultrasound Diagnostics in Reproductive Medicine

  Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.

  Recruiting Semmelweis University · Budapest, Budapest · NCT07810920

• Ultrasound changes in fibroids during relugolix‑estradiol‑norethisterone treatment.

  This project will see if relugolix‑estradiol‑norethisterone changes the ultrasound appearance of fibroids in premenopausal women with heavy menstrual bleeding.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT06953076

• Evaluating radiation treatment outcomes for uterine cancer

  This study looks at how different radiation treatments for uterine cancer affect patients and their side effects to help make treatments better in the future.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06774482

• Examining the effects of brachytherapy on gynecological cancers

  This study looks at how well brachytherapy works for women aged 18 to 80 with different types of gynecological cancers.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05242861

• Using reminders and self-sampling to boost cervical cancer screening participation

  This study is testing if sending text reminders and using self-sampling kits can help women at high risk for cervical cancer get screened more often.

  Recruiting at 6 sites Karolinska Institutet · Luleå, Norrbotten County and 5 other locations · NCT04061967

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.